COMMENTARY: BRCA1/2 Mutations, Vulnerability to Breast/Ovarian Cancer, and Current and Future Treatment Modalities. J. Can. Res. Updates. 2016;5(2): 45-46. doi:10.6000/1929-2279.2016.05.02.1